Cargando…

Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome

Heyde’s syndrome is defined as a triad of aortic stenosis, anemia due to angiodysplasia-related bleeding, and von Willebrand syndrome type 2A. It is a rare disease and a diagnostic challenge. Treatment modalities include symptomatic management, blood transfusions, aortic valve replacement, and medic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheema, Hira I, Roark, Russell, Hassan, Seemeen, Chakrala, Kalyan, Tharian, Benjamin, Anastasiou, Jiannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239735/
https://www.ncbi.nlm.nih.gov/pubmed/35783893
http://dx.doi.org/10.7759/cureus.25461
_version_ 1784737368879661056
author Cheema, Hira I
Roark, Russell
Hassan, Seemeen
Chakrala, Kalyan
Tharian, Benjamin
Anastasiou, Jiannis
author_facet Cheema, Hira I
Roark, Russell
Hassan, Seemeen
Chakrala, Kalyan
Tharian, Benjamin
Anastasiou, Jiannis
author_sort Cheema, Hira I
collection PubMed
description Heyde’s syndrome is defined as a triad of aortic stenosis, anemia due to angiodysplasia-related bleeding, and von Willebrand syndrome type 2A. It is a rare disease and a diagnostic challenge. Treatment modalities include symptomatic management, blood transfusions, aortic valve replacement, and medications such as octreotide. Here, we report the case of a patient who was resistant to symptomatic management, aortic valve replacement, as well as intravenous octreotide.
format Online
Article
Text
id pubmed-9239735
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-92397352022-07-02 Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome Cheema, Hira I Roark, Russell Hassan, Seemeen Chakrala, Kalyan Tharian, Benjamin Anastasiou, Jiannis Cureus Gastroenterology Heyde’s syndrome is defined as a triad of aortic stenosis, anemia due to angiodysplasia-related bleeding, and von Willebrand syndrome type 2A. It is a rare disease and a diagnostic challenge. Treatment modalities include symptomatic management, blood transfusions, aortic valve replacement, and medications such as octreotide. Here, we report the case of a patient who was resistant to symptomatic management, aortic valve replacement, as well as intravenous octreotide. Cureus 2022-05-29 /pmc/articles/PMC9239735/ /pubmed/35783893 http://dx.doi.org/10.7759/cureus.25461 Text en Copyright © 2022, Cheema et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Gastroenterology
Cheema, Hira I
Roark, Russell
Hassan, Seemeen
Chakrala, Kalyan
Tharian, Benjamin
Anastasiou, Jiannis
Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome
title Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome
title_full Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome
title_fullStr Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome
title_full_unstemmed Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome
title_short Comparison Between Intravenous and Intramuscular Octreotide in the Management of Heyde’s Syndrome
title_sort comparison between intravenous and intramuscular octreotide in the management of heyde’s syndrome
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239735/
https://www.ncbi.nlm.nih.gov/pubmed/35783893
http://dx.doi.org/10.7759/cureus.25461
work_keys_str_mv AT cheemahirai comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome
AT roarkrussell comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome
AT hassanseemeen comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome
AT chakralakalyan comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome
AT tharianbenjamin comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome
AT anastasioujiannis comparisonbetweenintravenousandintramuscularoctreotideinthemanagementofheydessyndrome